Edwards Lifesciences Corp. unveiled a new option in its heart valve franchise on Tuesday. The Irvine-based valve maker’s Ascendra procedure uses an aortic heart valve replacement system that is less ...

IRVINE, CA. -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark in Europe for valve-in-valve ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

MARSEILLE, FRANCE -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced unprecedented long-term durability results for ...

IRVINE, Calif., Dec. 21, 2020 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW), today announced that the first patient has been treated in the RESTORE clinical trial, which will evaluate the safety and ...

Edwards Lifesciences, a medical technology company based in the US, has announced the complete acquisition of Innovalve Bio Medical, which specialises in transcatheter heart valve devices. The ...

The FDA approved a new version of Edwards Lifesciences’ Sapien 3 transcatheter heart valve—coupling it with a self-expanding, stent-like device that helps reshape a malfunctioning pulmonary valve.

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...

Philips said Thursday it has received 510(k) clearance for a heart procedure visualization tool it developed with Edwards Lifesciences. The system, called EchoNavigator R5.0 with DeviceGuide, uses ...

With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is ...

VANCOUVER, Wash. (AP) — Glenn Baker was just 32 years old when he underwent a relatively new surgical procedure in 1966 to replace a heart valve. This week, the 82-year-old and his family will ...

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach ...